Skip Navigation

Clinical trial for preventing migraines

In this video

.AD.IXIC

Clinical trial for preventing migraines

CNBC's Meg Tirrell reports on data from clinical trials by Alder and its migraine drug ALD403.

01:57

Mon, Mar 28 20161:59 PM EDT

ServiceNow CEO on AI: Not a moment to think incrementally, this is a 'shift in the enterprise'

ServiceNow CEO on AI: Not a moment to think incrementally, this is a 'shift in the enterprise'

Nvidia CEO Jensen Huang: We're moving from world of software to producing digital intelligence

Nvidia CEO Jensen Huang: We're moving from world of software to producing digital intelligence

It's not a bull market outside of AI-related chips, says Ritholtz's Josh Brown

It's not a bull market outside of AI-related chips, says Ritholtz's Josh Brown

Here's why short-seller Spruce Point Capital is betting against Boot Barn

Here's why short-seller Spruce Point Capital is betting against Boot Barn

There's a 'strong case' for China entering a bull market, says KraneShares' Brendan Ahern

There's a 'strong case' for China entering a bull market, says KraneShares' Brendan Ahern

ServiceNow CEO on AI: Not a moment to think incrementally, this is a 'shift in the enterprise'

ServiceNow CEO on AI: Not a moment to think incrementally, this is a 'shift in the enterprise'

Nvidia CEO Jensen Huang: We're moving from world of software to producing digital intelligence

Nvidia CEO Jensen Huang: We're moving from world of software to producing digital intelligence

It's not a bull market outside of AI-related chips, says Ritholtz's Josh Brown

It's not a bull market outside of AI-related chips, says Ritholtz's Josh Brown

Here's why short-seller Spruce Point Capital is betting against Boot Barn

Here's why short-seller Spruce Point Capital is betting against Boot Barn

There's a 'strong case' for China entering a bull market, says KraneShares' Brendan Ahern

There's a 'strong case' for China entering a bull market, says KraneShares' Brendan Ahern